158 related articles for article (PubMed ID: 36733671)
1. Correlation of DEPDC5 rs1012068 and rs5998152 Polymorphisms with Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Zhu S; Tang Z; Zou M; Tan T; Tang Y; Chen Y; Liang B; Xie D; Yang Y; Xie S; Xie G; Dong X; Liu T; Tang Y; Yang J
J Oncol; 2023; 2023():5957481. PubMed ID: 36733671
[TBL] [Abstract][Full Text] [Related]
2. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the DEPDC5 rs1012068 polymorphism and the risk of HBV-related hepatocellular carcinoma.
Liu W; Ma N; Zhao D; Gao X; Zhang X; Yang L; Liu D
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):446-450. PubMed ID: 30683632
[TBL] [Abstract][Full Text] [Related]
4. Disheveled EGL-10 and pleckstrin domain-containing 5 rs1012068 T/G gene polymorphism among Egyptian chronic HCV-infected patients: disease progression and related complications.
Farhan HM; Abougabal K; Gaber HF; Attia D
Egypt J Immunol; 2022 Jul; 29(3):36-43. PubMed ID: 35758967
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma.
Zhang Y; Zhu SL; Chen J; Li LQ
Onco Targets Ther; 2016; 9():3249-57. PubMed ID: 27313470
[TBL] [Abstract][Full Text] [Related]
6. DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection.
Burza MA; Motta BM; Mancina RM; Pingitore P; Pirazzi C; Lepore SM; Spagnuolo R; Doldo P; Russo C; Lazzaro V; Fischer J; Berg T; Aghemo A; Cheroni C; De Francesco R; Fargion S; Colombo M; Datz C; Stickel F; Valenti L; Romeo S
Hepatology; 2016 Feb; 63(2):418-27. PubMed ID: 26517016
[TBL] [Abstract][Full Text] [Related]
7. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
8. Role of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.
Ma N; Zhang X; Yu F; Gao P; Fan Q; Liu L; Liu D
J Viral Hepat; 2014 Jul; 21(7):e29-38. PubMed ID: 25032264
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
Luo X; Wang Y; Shen A; Deng H; Ye M
BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
[TBL] [Abstract][Full Text] [Related]
10. Coinfection of
Madala S; MacDougall K; Surapaneni BK; Park R; Girotra M; Kasi A
J Clin Med Res; 2021 Dec; 13(12):530-540. PubMed ID: 35059071
[TBL] [Abstract][Full Text] [Related]
11. Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy.
Motomura T; Ono Y; Shirabe K; Fukuhara T; Konishi H; Mano Y; Toshima T; Yoshiya S; Muto J; Ikegami T; Yoshizumi T; Maehara Y
HPB Surg; 2012; 2012():185496. PubMed ID: 23132957
[TBL] [Abstract][Full Text] [Related]
12. Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis.
Yu JY; Hu F; Du W; Ma XL; Yuan K
J Chin Med Assoc; 2017 Apr; 80(4):191-203. PubMed ID: 28188097
[TBL] [Abstract][Full Text] [Related]
13. MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis.
Tian T; Wang M; Zhu W; Dai ZM; Lin S; Yang PT; Liu XH; Liu K; Zhu YY; Zheng Y; Liu M; Dai ZJ
Aging (Albany NY); 2017 Jan; 9(2):381-392. PubMed ID: 28148887
[TBL] [Abstract][Full Text] [Related]
14. Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis.
Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
Pathol Res Pract; 2020 Oct; 216(10):153099. PubMed ID: 32853942
[TBL] [Abstract][Full Text] [Related]
15. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
16. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
[TBL] [Abstract][Full Text] [Related]
17. Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis.
Zhu SL; Zhong JH; Gong WF; Li H; Li LQ
Onco Targets Ther; 2016; 9():2111-9. PubMed ID: 27143913
[TBL] [Abstract][Full Text] [Related]
18. Association of
Shi H; He H; Ojha SC; Sun C; Fu J; Yan M; Deng C; Sheng Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160486
[No Abstract] [Full Text] [Related]
19. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers.
Miki D; Ochi H; Hayes CN; Abe H; Yoshima T; Aikata H; Ikeda K; Kumada H; Toyota J; Morizono T; Tsunoda T; Kubo M; Nakamura Y; Kamatani N; Chayama K
Nat Genet; 2011 Jul; 43(8):797-800. PubMed ID: 21725309
[TBL] [Abstract][Full Text] [Related]
20. The association between three IL-6 polymorphisms and HBV-related liver diseases: a meta-analysis.
Chang L; Lan T; Wu L; Li C; Yuan Y; Liu Z
Int J Clin Exp Med; 2015; 8(10):17036-45. PubMed ID: 26770294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
